| Host Immune Factors (HIFs) |
| C-C motif chemokine 1 |
| HIF ID |
HIFM0016 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Enterococcus faecalis oral infection has been completely improved after elimination of M2b phenotype by CCL1 antisense oligodeoxynucleotide (ODN). |
[2] |
| Human beta defensin 3 |
| HIF ID |
HIFM0079 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
HBD-3 of 8g/ml against Enterococcus faecium nosocomial strains bactericidal activity with defined resistance phenotypes such as amoxycillin. |
[3] |
| Eosinophil cationic protein |
| HIF ID |
HIFM0094 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
The RNase 3 showed >10 bactericidal activity against Enterococcus faecium when the hemolytic activity of 11.2+0.1M or 11.2-0.1M and the peptide size reduction of 48%. |
[4] |
| Ribonuclease 7 |
| HIF ID |
HIFM0201 |
HIF Info
|
Class |
Antimicrobial peptide (AMP) |
| Description |
Antimicrobial activity RNase 7 (0.33M) was incubated without RNase inhibitor reduced the colony-forming units (CFUs) of Enterococcus faecium. |
[5] |
| Programmed death-ligand 1 |
| HIF ID |
HIFM0189 |
HIF Info
|
Class |
Checkpoint molecule (CM) |
| Description |
Enterococcus faecium enrichment contributed to better response to anti-PD-L1 therapy. |
[6] |
| Nucleotide binding oligomerization domain containing 2 signaling pathway |
| HIF ID |
HIFP0029 |
HIF Info
|
Class |
Signaling pathway (SP) |
| Description |
The abundance of Enterococcus faecium is associated with NOD2. |
[7] |
|
|
|
|
|
|